Christopher Tovey
Chief Executive Officer bij DESTINY PHARMA PLC
Profiel
Momenteel is Christopher John Tovey Chief Operating Officer bij GW Pharmaceuticals Plc. Hij is ook lid van de raad van bestuur van CanImGuide Therapeutics AB, GW Research Ltd. en GW Pharma Ltd. Voorheen was de heer Tovey Director-Vaccines Business Unit bij GlaxoSmithKline Plc en Vice President-Global Marketing Operations bij UCB SA. Hij behaalde een bachelorgraad aan de Universiteit van Liverpool.
Actieve functies van Christopher Tovey
Bedrijven | Functie | Begin |
---|---|---|
DESTINY PHARMA PLC | Chief Executive Officer | 01-09-2023 |
GW Research Ltd.
GW Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Research UK Ltd. is a private company that engages in researching and developing biotechnology. Jazz Pharmaceuticals Research UK Ltd. is based in Cambridge, UK. Founded in 1995. | Director/Board Member | 01-10-2012 |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Director/Board Member | - |
GW Pharma Ltd.
GW Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, GW Pharma Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in Histon, UK. GW Pharma was founded in 1999. | Director/Board Member | 01-10-2012 |
Eerdere bekende functies van Christopher Tovey
Bedrijven | Functie | Einde |
---|---|---|
JAZZ PHARMACEUTICALS PLC | Chief Operating Officer | 01-10-2022 |
GW PHARMACEUTICALS PLC | Chief Operating Officer | - |
UCB | Corporate Officer/Principal | 01-09-2012 |
GSK PLC | Corporate Officer/Principal | 01-01-2005 |
Opleiding van Christopher Tovey
The University of Liverpool | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
GSK PLC | Health Technology |
UCB | Health Technology |
DESTINY PHARMA PLC | Health Technology |
JAZZ PHARMACEUTICALS PLC | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
GW Pharmaceuticals Ltd.
GW Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology GW Pharmaceuticals Ltd. operates as an intermediate holding company and management company for investments in its subsidiaries. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
GW Research Ltd.
GW Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Research UK Ltd. is a private company that engages in researching and developing biotechnology. Jazz Pharmaceuticals Research UK Ltd. is based in Cambridge, UK. Founded in 1995. | Commercial Services |
GW Pharma Ltd.
GW Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, GW Pharma Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in Histon, UK. GW Pharma was founded in 1999. | Health Technology |